CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Dexmedetomidine 25mg  | ≥99%

CSNpharm

Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist with Ki value of 1.08 nM, which is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function.

More Information Supplier Page

Dexmedetomidine 100mg  | ≥99%

CSNpharm

Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist with Ki value of 1.08 nM, which is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function.

More Information Supplier Page

Dexmedetomidine 50mg  | ≥99%

CSNpharm

Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist with Ki value of 1.08 nM, which is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function.

More Information Supplier Page

Dexmedetomidine HCl 25mg  | ≥99%

CSNpharm

Dexmedetomidine is a selectively activator of presynaptic alpha-2 adrenoceptors located in the brain. This leads to inhibition of postsynaptic activation of adrenoceptors through inhibiting the release of norepinephrine from synaptic vesicles, thereby leading to analgesia, sedation and anxiolysis.

More Information Supplier Page

Dexmedetomidine HCl 10mg  | ≥99%

CSNpharm

Dexmedetomidine is a selectively activator of presynaptic alpha-2 adrenoceptors located in the brain. This leads to inhibition of postsynaptic activation of adrenoceptors through inhibiting the release of norepinephrine from synaptic vesicles, thereby leading to analgesia, sedation and anxiolysis.

More Information Supplier Page

Dexmedetomidine HCl 50mg  | ≥99%

CSNpharm

Dexmedetomidine is a selectively activator of presynaptic alpha-2 adrenoceptors located in the brain. This leads to inhibition of postsynaptic activation of adrenoceptors through inhibiting the release of norepinephrine from synaptic vesicles, thereby leading to analgesia, sedation and anxiolysis.

More Information Supplier Page

Dexmedetomidine HCl 5mg  | ≥99%

CSNpharm

Dexmedetomidine is a selectively activator of presynaptic alpha-2 adrenoceptors located in the brain. This leads to inhibition of postsynaptic activation of adrenoceptors through inhibiting the release of norepinephrine from synaptic vesicles, thereby leading to analgesia, sedation and anxiolysis.

More Information Supplier Page

DHBS 100mg  | ≥98%

CSNpharm

DHBS is used in conjunction with 4-aminoantipyrine(4-AAP) and hydrogen peroxide (H2O2) for chromogenic quantitation of peroxidase in coupled enzymatic reactions.

More Information Supplier Page

DHBS 1g  | ≥98%

CSNpharm

DHBS is used in conjunction with 4-aminoantipyrine(4-AAP) and hydrogen peroxide (H2O2) for chromogenic quantitation of peroxidase in coupled enzymatic reactions.

More Information Supplier Page

DHODH-IN-11 50mg  | ≥98%

CSNpharm

DHODH-IN-11, a leflunomide derivative, is a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with pKa of 5.03.

More Information Supplier Page

DHODH-IN-11 25mg  | ≥98%

CSNpharm

DHODH-IN-11, a leflunomide derivative, is a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with pKa of 5.03.

More Information Supplier Page

DHODH-IN-11 100mg  | ≥98%

CSNpharm

DHODH-IN-11, a leflunomide derivative, is a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with pKa of 5.03.

More Information Supplier Page

DHODH-IN-11 5mg  | ≥98%

CSNpharm

DHODH-IN-11, a leflunomide derivative, is a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with pKa of 5.03.

More Information Supplier Page

DHODH-IN-11 10mg  | ≥98%

CSNpharm

DHODH-IN-11, a leflunomide derivative, is a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with pKa of 5.03.

More Information Supplier Page

Diacerein 10mg  | ≥99%

CSNpharm

Diacerein is a symptomatic slow-acting medicine in osteoarthritis which can reduce the level of IL-1 receptors leading to fewer receptors to form heterodimer complexes.

More Information Supplier Page

Diacerein 100mg  | ≥99%

CSNpharm

Diacerein is a symptomatic slow-acting medicine in osteoarthritis which can reduce the level of IL-1 receptors leading to fewer receptors to form heterodimer complexes.

More Information Supplier Page

Diacerein 50mg  | ≥99%

CSNpharm

Diacerein is a symptomatic slow-acting medicine in osteoarthritis which can reduce the level of IL-1 receptors leading to fewer receptors to form heterodimer complexes.

More Information Supplier Page

Diaveridine HCl 250mg  | ≥99%

CSNpharm

Diaveridine HCl is a coccidiostat and inhibits dihydrofolate reductase. It can prevente folic acid synthesis in species of Pneumocystis. Diaveridine also has genotoxicity.

More Information Supplier Page